ConductScience.org, home

Library / Trials

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

NCT02534363, Phase 4, Completed, Fundación Marques de Valdecilla

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleNeurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upClinicalTrials.gov
NCT numberNCT02534363ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesPhase 4ClinicalTrials.gov
Enrollment136 participants, actualClinicalTrials.gov
Lead sponsorFundación Marques de ValdecillaClinicalTrials.gov
ConditionsSchizophrenia, Psychotic DisordersClinicalTrials.gov
InterventionsAripiprazole, Quetiapine, Ziprasidone, Cognitive batteryClinicalTrials.gov
First posted2015-08-27ClinicalTrials.gov
Last updated2017-03-14ClinicalTrials.gov

Registered outcomes 10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryGlobal cognitive index1 year
In order to calculate a measure of Global Cognitive Functioning (GCF) raw cognitive scores were reversed when appropriate before standardization so they all have the same direction (the higher, the better). According to previous methodology, the GCF was calculated as T-scores, with raw scores of a healthy comparison sample. T scores were converted to deficit scores that reflect presence and severity of cognitive impairment. Deficit scores on all tests were then "averaged" to create the GCF score.
ClinicalTrials.gov
SecondaryChange in information processing speed1 yearMeasured by Wechsler Adult Intelligence Scale (WAIS) - III digit symbol subtest (standard total score), Trail Making Test (TMT) trail A and Continuous Performance Test (CPT) reaction time.ClinicalTrials.gov
SecondaryChange in motor dexterity1 yearMeasured by Grooved Pegboard Test (time to complete with dominant hand).ClinicalTrials.gov
SecondaryChange in working memory1 yearMeasured by WAIS - III letter-number sequencing test (standard total score) and WAIS - III digits forward (standard total score).ClinicalTrials.gov
SecondaryChange in verbal learning1 yearMeasured by the Rey Auditory Verbal Learning Test (RAVLT) (trials 1-5).ClinicalTrials.gov
SecondaryChange in visuospatial abilities1 yearMeasured by the Rey Complex Figure (RCF) (copy figure).ClinicalTrials.gov
SecondaryChange in delayed memory1 yearMeasured by RAVLT (list recall and list recognition discrimination subscore) and RCF (delayed recall).ClinicalTrials.gov
SecondaryChange in attention1 yearMeasured by CPT (discrimination subscores).ClinicalTrials.gov
SecondaryChange in executive function1 year
Measured by TMT trail B, Stroop Test (color-word), the Zoo Map Test (first and second conditions), the Tower of London Test (ToL) (total correct and total moves score) and letter (FAS) and semantic (animal) fluency tests.
ClinicalTrials.gov
SecondaryChange in theory of mind1 yearMeasured by Eyes Task (total correct score).ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
29275855DERIVEDPubMed
29856773DERIVEDPubMed
30097769DERIVEDPubMed
35383335DERIVEDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 8

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Complex Figure Copy and RecallSecondary outcomeConductCognition
Continuous Performance TestSecondary outcomeConductCognition
Letter-Number Sequencing TaskSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Tower PlanningSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition
Verbal LearningSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)